Innovation lab driven by AI formed by AstraZeneca, Merck, Pfizer and Teva
US states sue generic firms over 'inflated' prices - PMLiVE
Pfizer scrambles to fill void after Teva stops making chemo drug often given to children | FiercePharma
Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA) - Insider Monkey
New innovation lab brings together pharma, biotech giants for AI therapeutics | The Times of Israel
Global Competition Review - Pfizer and Teva face new drug delay action
Pfizer in $2.15 Billion Settlement From Teva and Sun for Patent Infringement
Pfizer Reaches Settlement with Teva on Generic Viagra | IndustryWeek
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | FiercePharma
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Pfizer gets $2.15 billion settlement
Pfizer wins Viagra patent battle against Teva
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | FiercePharma
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Teva wins battle with Pfizer over Viagra patent | Managing Intellectual Property
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
Generic Viagra Half the Price Teva Pfizer
Teva Pharmaceuticals - Wikipedia
Generic Drug Maker Teva Settles With Pfizer Over Patent Dispute, In Pharma Court Battle
Pfizer Wins Lyrica Patent Infringement Case Against Teva and Other Generic Drug Manufacturers | American University Intellectual Property Brief
Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer Looks to Fill Void for Chemo Drug After Teva Discontinues Its Generic Version | BioSpace
Teva Pharmaceuticals - Wikipedia
Pfizer's Kindler KO'd by Teva's Yanai
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
